Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Advances in Diagnosis and Management of Myelodysplastic Syndromes

Watch the full ASH 2020 MDS Foundation Virtual Symposium on demand here!

Organized by the MDS Foundation with VJHemOnc supporting as official media partner

Co-Chairs: Mario Cazzola, MD (Pavia, Italy), Jane Churpek, MD (Madison, Wisconsin, USA)

Stephen Nimer
Welcome – About the MDS Foundation, Inc
Stephen Nimer Sylvester Comprehensive Cancer Center, Miami, FL, United States
Mario Cazzola
Program Overview and Objectives
Mario Cazzola University of Pavia, Pavia, Italy
Rafael Bejar
Challenges in MDS Diagnosis
Rafael Bejar University of California, San Diego, CA, United States
Rafael Bejar
Q&A with Rafael Bejar
Rafael Bejar University of California, San Diego, CA, United States
Amy DeZern
Managing MDS in the Wake of a Global Pandemic
Amy DeZern Thomas Jefferson University, Baltimore, MD, United States
Amy DeZern
Q&A with Amy DeZern
Amy DeZern Thomas Jefferson University, Baltimore, MD, United States
Venetoclax in Higher-Risk MDS/AML
Q&A with Katharina Götze
Saar Gill
Role of CAR T-Cells in Myeloid Malignancies: Lessons Learned from Lymphoid Malignancies
Saar Gill Perelman School of Medicine, Philadelphia, PA, United States
Saar Gill
Q&A with Saar Gill
Saar Gill Perelman School of Medicine, Philadelphia, PA, United States
Stéphane de Botton
Targeted Therapies (enasidenib, ivosidenib, APR-246)
Stéphane de Botton Gustave Roussy, Paris, France
Stéphane de Botton
Q&A with Stephane de Botton
Stéphane de Botton Gustave Roussy, Paris, France

For the latest updates from leading experts, visit The MDS Channel!

The content of VJHemOnc is intended for healthcare professionals